Cited by 37Pregnancy and preeclampsia studiesNeurological Complications and SyndromesReproductive System and Pregnancy

The Circulating Proangiogenic Factors CYR61 (CCN1) and NOV (CCN3) Are Significantly Decreased in Placentae and Sera of Preeclamptic Patients

Gellhaus, Alexandra, Schmidt, Markus, Dunk, Caroline, Lye, Stephen J., Winterhager, Elke·2007·Reproductive Sciences

Abstract

It is thought that preeclampsia results from a shallow invasion of the extravillous trophoblast into the decidua and maternal vessels, which in turn leads to hypoxia and uteroplacental insufficiency. Here, the authors focus on the expression of the proangiogenic secreted molecules CYR61 (CCN1) and NOV (CCN3) in human placentae during normal pregnancy compared with preeclamptic placentae. CYR61 and NOV are strongly expressed in endothelial cells as well as in the extravillous trophoblast, with increasing levels during placental development. Interestingly, the authors found significantly decreased levels in early preeclamptic placentae compared with matched controls. Whereas both CYR61 and NOV proteins are present at constant high levels in the sera of nonpregnant and pregnant women, in the sera of patients with early-onset preeclampsia, levels were significantly reduced. The authors suggest that the reduction of both CCN molecules in preeclampsia could be 1 reason underlying the failure of uterine vascular remodeling. Moreover, their low maternal serum levels could serve as biomarkers for early diagnosis of this disease.

Integrity signals

Registry

Crossref · 10.1177/1933719107309816

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • This finding is consistent with a role for CCN1 in placental angiogenesis and decidual tissue remodeling, and evidence suggests serum CCN1 levels may serve as a marker for early diagnosis of pre-eclampsia.

    “This finding is consistent with a role for CCN1 in placental angiogenesis and decidual tissue remodeling, and evidence suggests that serum levels of CCN1 may serve as a marker for early diagnosis of pre-eclampsia [96].”

    From CCN1/CYR61: the very model of a modern matricellular protein (2011) · cites this paper as [96]

Cites

Flagged first, then by citations

1 of the 23 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Gellhaus, A., Schmidt, M., Dunk, C., Lye, S. J., & Winterhager, E.
Affiliations
  • Essen University Hospital (DE)
  • Mount Sinai Hospital (CA)
Corresponding author
Gellhaus, Alexandra
Venue
Reproductive Sciences
Published
2007-12
Volume
14
Issue
S8
Pages
46-52
ISSN
  • 1933-7191 (ISSN-L)
  • 1933-7205
OpenAlex
W2114645446
Cited by
37
References
23
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 2 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 5 · 2013: 1 · 2012: 4
FWCI
2.34
Type
journal article
Language
en
Open access
closed
Locations
  • Reproductive Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (University of Western Australia) (submittedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Neurological Complications and Syndromes
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords
preeclampsia, CYR61, NOV, CCN3, connective tissue growth factor, placenta, extravillous trophoblast, angiogenesis, placental insufficiency, uterine vascular remodeling, maternal serum biomarkers, endothelial cells
MeSH terms
Female, Germany, Gestational Age, Humans, Ontario, Placenta, Pre-Eclampsia, Pregnancy, Biomarkers, Down-Regulation, Case-Control Studies, Immediate-Early Proteins, Intercellular Signaling Peptides and Proteins, Angiogenic Proteins, Connective Tissue Growth Factor, Nephroblastoma Overexpressed Protein, Cysteine-Rich Protein 61

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review